Skip to content

Study · Animal study (in vivo) · 2002

2 results

[Immune mechanisms of hepatoprotector effects of etomersol and thymogen].

Okovityĭ SV, Gaĭvoronskaia VV

Eksperimental'naia i klinicheskaia farmakologiia1 May 2002Cited by 1 (Europe PMC)

PMID12227096 (opens in a new tab)PepBankPUB-12227096
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In thymectomized animals, thymogen lost its hepatoprotective activity.

    In plain wordsIn animals without a thymus, thymogen lost its liver-protective activity.

    Peptide
    Thymogen (oglufanide)
    Outcome
    DecreaseHepatoprotective activity after thymectomy
    Study

    n: not reported in source

    Thymectomized experimental animals
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Both thymogen and etomerzol loss the hepatoprotector activity on the background of thymectomy, but still produce an immunomodulant effect by stimulating the production of antibody-forming cells in the spleen in response to changes in the immune system induced by various stressor factors (thymectomy,…
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In animals exposed to thymectomy, hepatectomy, or both, thymogen stimulated splenic antibody-forming cell production.

    In plain wordsIn animals after thymus removal, partial liver removal, or both, thymogen stimulated production of antibody-forming cells in the spleen.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseSplenic antibody-forming cell production
    Study

    n: not reported in source

    Experimental animals exposed to thymectomy, hepatectomy, or both
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Both thymogen and etomerzol loss the hepatoprotector activity on the background of thymectomy, but still produce an immunomodulant effect by stimulating the production of antibody-forming cells in the spleen in response to changes in the immune system induced by various stressor factors (thymectomy,…

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.